On Friday, 1st August 2025, Prof. Barnabas Nawangwe, Vice Chancellor of Makerere University, officially inaugurated the newly upgraded Research Centre for Tropical Diseases and Vector Control (RTC) Lab at the College of […]
Whilst the burden of human sleeping sickness has been reduced by more than 95%, Nagana – caused by different species of trypanosomes- continues to undermine livestock productivity across vast swathes […]
We’re excited to share GALVmed’s 2024 Year in Review. From product and market development to strategic partnerships and regulatory progress, this comprehensive report highlights the milestones and achievements that shaped […]
GALVmed is excited to announce the search for a new Chief Executive Officer as current CEO, Carolin Schumacher, prepares to step down later this year after providing exceptional leadership and […]
The control of Foot and Mouth Disease (FMD) in the Eastern Africa Region is now a step closer thanks to a newly registered first ever quadrivalent FMD vaccine tailored for […]
In a world of significant technology advancements, data is becoming increasingly important. Data serves as the foundation for machine learning models to identify trends and patterns, which is often used […]
We are pleased to present GALVmed’s Year in Review for 2023. This comprehensive report summarises the accomplishments and milestones that shaped the course of our journey and endeavours over the […]
GALVmed and Elanco Animal Health will convene stakeholders on sustainable tick control and acaricide management in Kampala, Uganda. The event which will be held on the December 6 and 7, […]
News originally published by S&P Global Multiple partners have created a taskforce to tackle African animal trypanosomiasis. S&P Global’s head of animal health Joseph Harvey spoke to GALVmed’s AAT development […]
GALVmed is pleased to announce the appointment of Dr Karelle de Luca as Head of Research & Development, effective August 27th, 2023. Dr de Luca is a researcher with deep […]
